Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors
Clinical trial NCT02881190 · COMPLETED
Trial details
- NCT number
- NCT02881190
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-14
- Primary completion
- 2019-06-27
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.